Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 15, Number 2—February 2009


Prospective Surveillance of Invasive Group A Streptococcal Disease, Fiji, 2005–2007

Andrew C. SteerComments to Author , Adam Jenney, Joseph Kado, Michael F. Good, Michael Batzloff, Lepani Waqatakirewa, E. Kim Mullholland, and Jonathan R. Carapetis
Author affiliations: University of Melbourne, Melbourne, Victoria, Australia (A.C. Steer, A. Jenney, E.K. Mullholland, J.R. Carapetis); Ministry of Health, Suva, Fiji (J. Kado, L. Waqatakirewa); Queensland Institute of Medical Research, Brisbane, Queensland, Australia (M.F. Good, M. Batzloff); London School of Hygiene and Tropical Medicine, London, UK (E.K. Mullholand); Menzies School of Health Research, Casuarina, Northern Territory, Australia (J.R. Carapetis)

Main Article

Table 3

Underlying coexisting medical conditions in patients with invasive GAS disease, Fiji, 2005–2007

Condition No. (%) patients
Diabetes 25 (42)
Renal disease 13 (22)
Cardiac disease 13 (22)
Malignancy 5 (8)
Immunosuppression 2 (3)
Lung disease 3 (5)
Liver disease
1 (2)
Any coexisting condition 38 (63)
Only 1 coexisting condition 21 (35)
2 coexisting conditions† 11 (18)
>2 coexisting condition† 6 (10)

*GAS, group A streptococci.
†Nine patients had diabetes and renal disease.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO